Volume 21, Issue 11 e13120
OBESITY COMORBIDITIES/ASSESSMENT

Usefulness of the Edmonton Obesity Staging System for stratifying the presence and severity of weight-related health problems in clinical and community settings: A rapid review of observational studies

Evan Atlantis

Corresponding Author

Evan Atlantis

School of Nursing and Midwifery, Western Sydney University, Penrith, New South Wales, Australia

School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia

Correspondence

Evan Atlantis, School of Nursing and Midwifery, Western Sydney University, Campbelltown Campus, Locked Bag 1797, Penrith, New South Wales 2751, Australia.

Email: [email protected]

Search for more papers by this author
Mehdi Sahebolamri

Mehdi Sahebolamri

School of Nursing and Midwifery, Western Sydney University, Penrith, New South Wales, Australia

Department of Endocrinology (Obesity), Nepean Hospital, Nepean Blue Mountains Local Health District, Kingswood, New South Wales, Australia

Search for more papers by this author
Birinder S. Cheema

Birinder S. Cheema

School of Health Sciences and the National Institute of Complementary Medicine, Western Sydney University, Penrith, New South Wales, Australia

Search for more papers by this author
Kathryn Williams

Kathryn Williams

Department of Endocrinology (Obesity), Nepean Hospital, Nepean Blue Mountains Local Health District, Kingswood, New South Wales, Australia

Charles Perkins Centre–Nepean, The University of Sydney, Kingswood, New South Wales, Australia

Search for more papers by this author
First published: 19 August 2020
Citations: 36

Summary

This rapid review aimed to examine the usefulness of the Edmonton Obesity Staging System (EOSS) for stratifying the presence and severity of weight-related health problems in clinical and community settings. We searched PubMed, CINAHL and ProQuest for records from 2009 to May 2020. We considered observational studies in participants with overweight or obesity that investigated the risk of any clinical outcome associated with increasing EOSS. We reviewed and appraised 20 observational studies (cohort = 4, case series = 7, cross-sectional = 9) published between 2011 and 2020. Of 12 studies in clinical populations, the EOSS was most consistently associated with an increased risk of postoperative complications following bariatric surgery, especially for EOSS 3–4, and inversely associated with weight loss, treatment time and resolution of hypertension following bariatric surgery and clinical weight management. Of eight studies in community populations, the EOSS most consistently predicted mortality outcomes, especially for EOSS 3, and was associated with polypharmacy, service use and poorer work outcomes. Studies reported diverse EOSS definitions and outcomes, which slightly weakens the overall evidence base. The EOSS should be routinely used for predicting risks and benefits of surgical and nonsurgical weight management, but it should be applied with caution for population health planning.

CONFLICT OF INTERESTS

E.A. is President of the National Association of Clinical Obesity Services (NACOS) and in the last 12 months has received honoraria from Novo Nordisk Pharmaceuticals Pty Ltd for projects unrelated to this paper. K.W. is Vice President of the NACOS and in the last 12 months has received honoraria from Novo Nordisk Pharmaceuticals Pty Ltd. for projects unrelated to this paper. M.S. is employed on a grant from NACOS and Western Sydney University on a project unrelated to this paper. No conflict of interest was declared for B.S.C.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.